Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infliximab for IVIG-resistant Kawasaki Disease
NCT02298062Phase 3Completed
- Sponsor
- Fudan University
- Start
- Jan 2013
- Primary completion
- Jul 2015
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of infliximab in Kawasaki disease (KD), sponsored by Fudan University. Started Jan 2013; status: completed.
02
Drugs
infliximab
03
Conditions
Kawasaki disease (KD)
Beyond the preview
Go deeper on NCT02298062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02298062.